Researchers at Georgia State University have developed an influenza vaccine made with nanoparticles that can be administered through the nose. This intranasal vaccine contributed to multifaceted immune responses, leading to robust cross protection against influenza in mice. These comprehensive immune responses and cross protection were long lasting, exhibiting defense from influenza virus over six months after immunization.
An official website of the United States government.